Jundishapur Journal of Microbiology

Published by: Kowsar

Co-Expression of hbha and mtb32C Genes from Mycobacterium tuberculosis H37Rv in a Prokaryotic System

Roghaye Teimourpour 1 , Hadi Peeridogaheh 1 , Mohsen Arzanlou 1 , Aida Gholoobi 3 , Mojtaba Sankian 4 and Zahra Meshkat 2 , *
Authors Information
1 Department of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, IR Iran
2 Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, IR Iran
3 Department of Modern Sciences and Technologies, School of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
4 Department of Immunology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
Article information
  • Jundishapur Journal of Microbiology: February 2018, 11 (2); e14030
  • Published Online: January 13, 2018
  • Article Type: Research Article
  • Received: May 24, 2017
  • Revised: November 8, 2017
  • Accepted: December 16, 2017
  • DOI: 10.5812/jjm.14030

To Cite: Teimourpour R, Peeridogaheh H, Arzanlou M, Gholoobi A, Sankian M, et al. Co-Expression of hbha and mtb32C Genes from Mycobacterium tuberculosis H37Rv in a Prokaryotic System, Jundishapur J Microbiol. 2018 ; 11(2):e14030. doi: 10.5812/jjm.14030.

Abstract
Copyright © 2018, Jundishapur Journal of Microbiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
6. Conclusions
Acknowledgements
References
  • 1. Organization WH. Global tuberculosis report. 2014. Available from: www.who.int/tb.
  • 2. Dara M, Dadu A, Kremer K, Zaleskis R, Kluge HH. Epidemiology of tuberculosis in WHO European Region and public health response. Eur Spine J. 2013;22 Suppl 4:549-55. doi: 10.1007/s00586-012-2339-3. [PubMed: 22565803].
  • 3. Yilmaz N, Zehra Aydin S, Inanc N, Karakurt S, Direskeneli H, Yavuz S. Comparison of QuantiFERON-TB Gold test and tuberculin skin test for the identification of latent Mycobacterium tuberculosis infection in lupus patients. Lupus. 2012;21(5):491-5. doi: 10.1177/0961203311430700. [PubMed: 22140142].
  • 4. Herrera V, Perry S, Parsonnet J, Banaei N. Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection. Clin Infect Dis. 2011;52(8):1031-7. doi: 10.1093/cid/cir068. [PubMed: 21460320].
  • 5. Ribeiro-Guimaraes ML, Pessolani MC. Comparative genomics of mycobacterial proteases. Microb Pathog. 2007;43(5-6):173-8. doi: 10.1016/j.micpath.2007.05.010. [PubMed: 17611072].
  • 6. Rindi L, Lari N, Garzelli C. Search for genes potentially involved in Mycobacterium tuberculosis virulence by mRNA differential display. Biochem Biophys Res Commun. 1999;258(1):94-101. doi: 10.1006/bbrc.1999.0591. [PubMed: 10222241].
  • 7. Menozzi FD, Bischoff R, Fort E, Brennan MJ, Locht C. Molecular characterization of the mycobacterial heparin-binding hemagglutinin, a mycobacterial adhesin. Proc Natl Acad Sci U S A. 1998;95(21):12625-30. [PubMed: 9770536].
  • 8. Vidal Pessolani MC, Marques MA, Reddy VM, Locht C, Menozzi FD. Systemic dissemination in tuberculosis and leprosy: do mycobacterial adhesins play a role?. Microbes Infect. 2003;5(7):677-84. [PubMed: 12787744].
  • 9. Locht C, Hougardy JM, Rouanet C, Place S, Mascart F. Heparin-binding hemagglutinin, from an extrapulmonary dissemination factor to a powerful diagnostic and protective antigen against tuberculosis. Tuberculosis (Edinb). 2006;86(3-4):303-9. doi: 10.1016/j.tube.2006.01.016. [PubMed: 16510310].
  • 10. Guerrero GG, Feunou F P, Locht C. The coiled-coil N-terminal domain of the heparin-binding haemagglutinin is required for the humoral and cellular immune responses in mice. Mol Immunol. 2008;46(1):116-24. doi: 10.1016/j.molimm.2008.07.009.
  • 11. Sato K, Tomioka H, Shimizu T, Gonda T, Ota F, Sano C. Type II alveolar cells play roles in macrophage-mediated host innate resistance to pulmonary mycobacterial infections by producing proinflammatory cytokines. J Infect Dis. 2002;185(8):1139-47. doi: 10.1086/340040. [PubMed: 11930324].
  • 12. Rouanet C, Debrie AS, Lecher S, Locht C. Subcutaneous boosting with heparin binding haemagglutinin increases BCG-induced protection against tuberculosis. Microbes Infect. 2009;11(13):995-1001. doi: 10.1016/j.micinf.2009.07.005. [PubMed: 19635582].
  • 13. Guerrero GG, Locht C. Recombinant HBHA boosting effect on BCG-induced immunity against Mycobacterium tuberculosis infection. Clin Dev Immunol. 2011;2011:730702. doi: 10.1155/2011/730702. [PubMed: 21647410].
  • 14. Hougardy JM, Schepers K, Place S, Drowart A, Lechevin V, Verscheure V, et al. Heparin-binding-hemagglutinin-induced IFN-gamma release as a diagnostic tool for latent tuberculosis. PLoS One. 2007;2(10). e926. doi: 10.1371/journal.pone.0000926. [PubMed: 17912342].
  • 15. Bruggemann H, Gottschalk G. Insights in metabolism and toxin production from the complete genome sequence of Clostridium tetani. Anaerobe. 2004;10(2):53-68. doi: 10.1016/j.anaerobe.2003.08.001. [PubMed: 16701501].
  • 16. Skeiky YAW, Alderson MR, Ovendale PJ, Guderian JA, Brandt L, Dillon DC, et al. Differential Immune Responses and Protective Efficacy Induced by Components of a Tuberculosis Polyprotein Vaccine, Mtb72F, Delivered as Naked DNA or Recombinant Protein. J Immunol. 2004;172(12):7618-28. doi: 10.4049/jimmunol.172.12.7618.
  • 17. Masungi C, Temmerman S, Van Vooren JP, Drowart A, Pethe K, Menozzi FD, et al. Differential T and B cell responses against Mycobacterium tuberculosis heparin-binding hemagglutinin adhesin in infected healthy individuals and patients with tuberculosis. J Infect Dis. 2002;185(4):513-20. doi: 10.1086/338833. [PubMed: 11865404].
  • 18. Baghani A, Youssefi M, Safdari H, Teimourpour R, Meshkat Z. Designing and Construction Pcdna3.1 Vector Encoding Cfp10 Gene of Mycobacterium tuberculosis. Jundishapur J Microbiol. 2015;8(10). e23560. doi: 10.5812/jjm.23560. [PubMed: 26587210].
  • 19. Teimourpour R, Sadeghian A, Meshkat Z, Esmaelizad M, Sankian M, Jabbari AR. Construction of a DNA Vaccine Encoding Mtb32C and HBHA Genes of Mycobacterium tuberculosis. Jundishapur J Microbiol. 2015;8(8). e21556. doi: 10.5812/jjm.21556. [PubMed: 26464766].
  • 20. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold spring harbor laboratory press; 1989.
  • 21. Skeiky YA, Alderson MR, Ovendale PJ, Guderian JA, Brandt L, Dillon DC, et al. Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein. J Immunol. 2004;172(12):7618-28. [PubMed: 15187142].
  • 22. van de Vosse E, Hoeve MA, Ottenhoff TH. Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae. Lancet Infect Dis. 2004;4(12):739-49. doi: 10.1016/S1473-3099(04)01203-4. [PubMed: 15567123].
  • 23. Lamberti M, Uccello R, Monaco MGL, Muoio M, Feola D, Sannolo N, et al. Tuberculin skin test and Quantiferon test agreement and influencing factors in tuberculosis screening of healthcare workers: a systematic review and meta-analysis. J Occup Med Toxicol. 2015;10:2. doi: 10.1186/s12995-015-0044-y. [PubMed: 25670962].
  • 24. Druszczynska M, Kowalewicz-Kulbat M, Fol M, Wlodarczyk M, Rudnicka W. Latent M. tuberculosis infection--pathogenesis, diagnosis, treatment and prevention strategies. Pol J Microbiol. 2012;61(1):3-10. [PubMed: 22708341].
  • 25. Lalvani A, Pareek M. A 100 year update on diagnosis of tuberculosis infection. Br Med Bull. 2010;93:69-84. doi: 10.1093/bmb/ldp039. [PubMed: 19926636].
  • 26. Kunst H. Diagnosis of latent tuberculosis infection: the potential role of new technologies. Respir Med. 2006;100(12):2098-106. doi: 10.1016/j.rmed.2006.02.032. [PubMed: 16650976].
  • 27. Norton BL, Holland DP. Current management options for latent tuberculosis: a review. Infect Drug Resist. 2012;5:163-73. doi: 10.2147/IDR.S29180. [PubMed: 23226700].
  • 28. Nayak S, Acharjya B. Mantoux test and its interpretation. Indian Dermatol Online J. 2012;3(1):2-6. doi: 10.4103/2229-5178.93479. [PubMed: 23130251].
  • 29. Blumberg HM, Kempker RR. Interferon-gamma release assays for the evaluation of tuberculosis infection. JAMA. 2014;312(14):1460-1. doi: 10.1001/jama.2014.4928. [PubMed: 25291583].
  • 30. Dheda K, van Zyl-Smit RN, Meldau R, Meldau S, Symons G, Khalfey H, et al. Quantitative lung T cell responses aid the rapid diagnosis of pulmonary tuberculosis. Thorax. 2009;64(10):847-53. doi: 10.1136/thx.2009.116376. [PubMed: 19592392].
  • 31. Trajman A, Steffen RE, Menzies D. Interferon-gamma release assays versus tuberculin skin testing for the diagnosis of latent tuberculosis infection: an overview of the evidence. Pulm Med. 2013. 2013:601737. doi: 10.1155/2013/601737. [PubMed: 23476763].
  • 32. Pang CS, Shen YC, Tian PW, Zhu J, Feng M, Wan C, et al. Accuracy of the interferon-gamma release assay for the diagnosis of tuberculous pleurisy: an updated meta-analysis. PeerJ. 2015;3. e951. doi: 10.7717/peerj.951. [PubMed: 26038718].
  • 33. Host H, Drobecq H, Locht C, Menozzi FD. Enzymatic methylation of the Mycobacterium tuberculosis heparin-binding haemagglutinin. FEMS Microbiol Lett. 2007;268(2):144-50. doi: 10.1111/j.1574-6968.2007.00636.x. [PubMed: 17263844].
  • 34. Kim KH, Yang CS, Shin AR, Jeon SR, Park JK, Kim HJ, et al. Mycobacterial Heparin-binding Hemagglutinin Antigen Activates Inflammatory Responses through PI3-K/Akt, NF-kappaB, and MAPK Pathways. Immune Netw. 2011;11(2):123-33. doi: 10.4110/in.2011.11.2.123. [PubMed: 21637390].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments